Using single-cell technology to create human antibody-based therapeutics
Drug Discovery World
FEBRUARY 6, 2023
The company is co-founded by former team leaders and multi-disciplinary tool builders from 10x Genomics. Taking a human-first approach, Infinimmune is leveraging single-cell technology to create truly human antibody-based therapeutics directly derived from the human immune system. This has consequences for safety and efficacy.
Let's personalize your content